Advertisement

Current Approach and Treatment in Acute Atrial Fibrillation

  • G. Chiarandà
  • A. Busà
  • A. Lazzaro
  • T. Regolo
Conference paper

Abstract

In the clinical setting, the most frequently observed arrhythmia is atrial fibrillation (AF). Its prevalence is rising [1], and at present it involves 0.3%-0.4% of the general population. There are 2.3 million cases in the USA, and the projection for the year 2050 is about 5.6 millions [2]. Several clinical surveys, including the Framingham Heart Study [3], indicate a steady increase in the incidence and prevalence of AF in the elderly, starting with 0.1% in subjects below 55 years of age, and reaching 9% in those over 80 years old. This is in agreement with the Cardiovascular Heart Study, which found a 5% prevalence of AF in subjects older than 65 years [4].

Keywords

Atrial Fibril Sinus Rhythm Antiarrhythmic Drug Atrial Flutter Ventricular Rate 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Reference

  1. 1.
    Braunwald E (1997) Shattuck lecture. Cardiovascular medicine at the turn of the millennium: triumphs, concerns and opportunities. N Engl J Med 337:1360–1369PubMedCrossRefGoogle Scholar
  2. 2.
    Go AS, Hylek EM, Phillips KA et al (2001) Prevalence of diagnosed atrial fibrillation in adults. JAMA 285:2370–2375PubMedCrossRefGoogle Scholar
  3. 3.
    Wolf PA, Benjamin EJ, Belanger AJ et al (1996) Secular trends in the prevalence of atrial fibrillation. The Framingham Study. Am Heart J 131:790–795PubMedCrossRefGoogle Scholar
  4. 4.
    Furberg CD, Psaty BM, Manolio TA (1994) Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am J Cardiol 74:236–241PubMedCrossRefGoogle Scholar
  5. 5.
    Narayan SM, Cain ME, Smith GP (1997) Atrial fibrillation. Lancet 350:943–950PubMedCrossRefGoogle Scholar
  6. 6.
    Benjamin EJ, Wolf PA, D’Agostino RB (1998) Impact of atrial fibrillation on the risk of death. The Framingham Heart Study. Circulation 98:946–952PubMedCrossRefGoogle Scholar
  7. 7.
    Bialy D, Lehman MH, Schumaker DN et al (1992) Hospitalization for arrhythmias in the United States: importance of atrial fibrillation. J Am Coll Cardiol 19:41Google Scholar
  8. 8.
    Fuster V, Ryden LE, Asinger RW et al (2001) Guidelines for the management of patients with atrial fibrillation. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to develop guidelines for the management of patients with atrial fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology. Eur Heart J 22:1852–1923PubMedCrossRefGoogle Scholar
  9. 9.
    Falk RH (2001) Atrial fibrillation. N Engl J Med 344:1067–1078PubMedCrossRefGoogle Scholar
  10. 10.
    Albers JW, Dale JE, Laupacis A, Manning WJ, Petersen P, Singer DE (2001) Antithrombotic therapy in atrial fibrillation. Chest 11:194S–206SCrossRefGoogle Scholar
  11. 11.
    Laupacis A, Albers G, Dunn M, Feinberg W (1992) Antithrombotic therapy in atrial fibrillation. Chest 102 [Suppl 41:426S–433SPubMedCrossRefGoogle Scholar
  12. 12.
    Prystowsky EN, Benson DW, Fuster V et al (1996) Management of patients with atrial fibrillation. A statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology, American Heart Association. Circulation 93:1262–1277PubMedCrossRefGoogle Scholar
  13. 13.
    Stoddard MF, Dawkins PR, Prince CR,Ammash NM (1995) Left atrial thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiographic study. J Am Coll Cardiol 25:452–459PubMedGoogle Scholar
  14. 14.
    Danias PG, Caufield TA, Weigner MJ et al (1998) Likelihood of spontaneous conversion of atrial fibrillation to sinus rhythm. J Am Coll Cardiol 31:588–592PubMedCrossRefGoogle Scholar
  15. 15.
    Donovan KD, Power BM, Hockings BEF, Dobb GJ, Lee KY (1995) Intravenous flecainide versus amiodarone for recent-onset atrial fibrillation. Am J Cardiol 75:693–697PubMedCrossRefGoogle Scholar
  16. 16.
    Boriani G, Biffi M, Capucci A, Pergolini F, Botto GL, Branzi A, Magnani B (1999) La cardioversione farmacologica della fibrillazione atriale. G Ital Aritmol Cardiostim 2:7–13Google Scholar
  17. 17.
    Daoul EG, Hummel JD, Augostini R, Williams S, Kalbfleisch SJ (2000) Effect of verapamil on immediate recurrence of atrial fibrillation. J Cardiovasc Electrophysiol 11:1231–1237CrossRefGoogle Scholar
  18. 18.
    Lai LP, Lin JL, Lien WP, Tseng JZ, Huang SK (2000) Intravenous sotalol decreases transthoracic cardioversion energy requirement for chronic atrial fibrillation in humans: assessment of the electrophysiological effects by biatrial basket electrodes. J Am Coll Cardiol 35:1434–1441PubMedCrossRefGoogle Scholar
  19. 19.
    Van Noord T, Van Gelder IC, Schoonderwerd BA, Crijns HJ (2000) Immediate reinitiation of atrial fibrillation after electrical cardioversion predicts subsequent pharmacologic and electrical conversion to sinus rhythm with amiodarone. Am J Cardiol 86:1384–1385PubMedCrossRefGoogle Scholar
  20. 20.
    Oral H, Souza JJ, Michaud JF (1999) Facilitating transthoracic cardioversion of atrial fibrillation with ibutilide pretreatment. N Engl J Med 340:1849–1854PubMedCrossRefGoogle Scholar
  21. 21.
    Mittal S, Ayati S, Stein KM et al (2000) Transthoracic cardioversion of atrial fibrillation. Comparison of rectilinear biphasis versus damped sine wave monophasic shock. Circulation 101:1282PubMedCrossRefGoogle Scholar
  22. 22.
    Saliba W, Juratli N, Chung MK et al (1999) Higher energy synchronized external direct current cardioversion for refractory atrial fibrillation. J Am Coll Cardiol 34:2031–2034PubMedCrossRefGoogle Scholar
  23. 23.
    Cooper RA, Alferness CA, Smith WM, Ideker RE (1993) Internal cardioversion of atrial fibrillation in sheep. Circulation 87:1673–1686PubMedCrossRefGoogle Scholar
  24. 24.
    Boriani B, Biggi M, Capucci A et al (1999) Favorable effects of flecainide in transvenous internal cardioversion of AF. J Am Coll Cardiol 33:333–341PubMedCrossRefGoogle Scholar
  25. 25.
    Santini M, Pandozi C, Colivicchi F, Ammirati F, Carmela Scianaro M, Castro A, Lamberti F, Gentilucci G (2000) Transoesophageal low-energy cardioversion of atrial fibrillation. Results with the oesophageal-right atrial lead configuration. Eur Heart J 21:848–855PubMedCrossRefGoogle Scholar
  26. 26.
    Hurst JW, Paulk EA, Proctor HD et al (1964) Management of patients with atrial fibrillation. Am J Med 37:728PubMedCrossRefGoogle Scholar
  27. 27.
    Borgeat A, Goy JJ, Maendly R et al (1985) Flecainide versus quinidine for conversion of recent onset atrial fibrillation to sinus rhythm. Am J Cardiol 58:496–498CrossRefGoogle Scholar
  28. 28.
    Capucci A, Boriani G, Rubino I et al (1993) A controlled study on oral propafenone versus digoxin plus quinidine in converting recent onset atrial fibrillation to sinus rhythm. Int J Cardiol 43:305–313CrossRefGoogle Scholar
  29. 29.
    Halinen MO, Huttunen M, Paakkinen S et al (1995) Comparison of sotalol with digoxin-quinidine for conversion of acute atrial fibrillation to sinus rhythm (The Sotalol-Digoxin-Quinidine Trial). Am J Cardiol 76:495–498PubMedCrossRefGoogle Scholar
  30. 30.
    Grace AA, Camm, AJ (1998) Quinidine. N Engl J Med 33:35–45Google Scholar
  31. 31.
    Coplen SE, Antmann EM, Berlin JA et al (1990) Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomized control trials. Circulation 82:1106–1116PubMedCrossRefGoogle Scholar
  32. 32.
    De Haas DD, Tagliaferro EH, Amin MN et al (1988) Intravenous procainamide for the conversion of new onset atrial fibrillation in emergency department setting. J Emerg Med 6:185–187PubMedCrossRefGoogle Scholar
  33. 33.
    Volgman AS, Carberry PA, Stamgler B et al (1998) Conversion efficacy and safety of intravenous ibutilide compared with intravenus procainamide in patients with atrial flutter or fibrillation. J Am Coll Cardiol 31:1414–1419PubMedCrossRefGoogle Scholar
  34. 34.
    Mattioli AV, Lucchi VR, Vivoli D et al (1998) Propafenone versus procainamide for conversion of atrial fibrillation to sinus rhythm. Clin Cardiol 21:763–766PubMedCrossRefGoogle Scholar
  35. 35.
    Capucci A, Villani GQ, Piepoli MS et al (1999) The role of IC antiarrhythmic drugs in terminating atrial fibrillation. Curr Opin Cardiol 14:48CrossRefGoogle Scholar
  36. 36.
    Blanc JJ,Voinov C, Marek M et al (1999) Comparison of oral loading dose of propafenone and amiodarone for converting recent onset atrial fibrillation. PARSIFAL Study Group. Am J Cardiol 84:1029–1032PubMedCrossRefGoogle Scholar
  37. 37.
    Capucci A, Villani GQ, Aschieri D et al (1999) Safety of oral propafenone in the conversion of recent onset atrial fibrillation to sinus rhythm: a prospective parallel placebo-controlled trial. Int J Cardiol 68:187–196PubMedCrossRefGoogle Scholar
  38. 38.
    Botto GL, Bonini W, Broffoni T et al (1998) Randomized, cross over controlled comparison of oral loading versus intravenous infusion of propafenone in recent onset atrial fibrillation. Pacing Clin Electrophysiol 21(11Part2):2480–2484PubMedCrossRefGoogle Scholar
  39. 39.
    Boriani G, Capucci A, Botto GL et al (1998) Conversion of recent-onset atrial fibrillation to sinus rhythm: effects of different drug protocols. Pacing Clin Electrophysiol 21(1lPart2):2470–2474PubMedCrossRefGoogle Scholar
  40. 40.
    Khan IA (2001) Single oral loading dose of propafenone for pharmacological cardioversion of recent-onset atrial fibrillation. J Am Coll Cardiol 37:542–547PubMedCrossRefGoogle Scholar
  41. 41.
    Botto JL, Bonini W, Broffoni T et al (1996) Conversion of recent-onset atrial fibrillation with single oral dose of propafenone: is in-hospital admission absolutely necessary? Pacing Clin Electrophysiol 19(Part2): 1939–1943PubMedCrossRefGoogle Scholar
  42. 42.
    Galve E, Rius T, Ballester R et al (1996) Intravenous amiodarone in treatment of recent-onset atrial fibrillation: results of randomized controlled study. J Am Coll Cardiol 27:1079–1082PubMedCrossRefGoogle Scholar
  43. 43.
    Negrini N, Gibelli G, De Ponti C (1991) Propafenone compared with amiodarone for conversion of paroxysmal atrial fibrillation to sinus rhythm (abstract). J Am Coll Cardiol 17:131AGoogle Scholar
  44. 44.
    Hou ZY, Chang MS, Chen CY et al (1995) Acute treatment of recent-onset atrial fibrillation and flutter with a tailored dosing regimen of intravenous amiodarone. A randomized digoxin-controlled study. Eur Heart J 16:521–528PubMedGoogle Scholar
  45. 45.
    Cotter J, Blatt A, Kaluski E et al (1999) Conversion of recent-onset paroxysmal atrial fibrillation to normal sinus rhythm: the effects of no treatment and high-dose amiodarone. A randomized placebo-controlled study. Eur Heart J 20:1833–1842PubMedCrossRefGoogle Scholar
  46. 46.
    Hilleman DE, Spinier SA (2002) Conversion of recent-onset atrial fibrillation with intravenous amiodarone: a meta-analysis of randomized controlled trial. Pharmacotherapy 22:66–74PubMedCrossRefGoogle Scholar
  47. 47.
    Falk RH (1992) Pro arrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med 117:141–150PubMedCrossRefGoogle Scholar
  48. 48.
    Noogard BL, Watchell K, Christensen PD et al (1997) Efficacy and safety of intravenously administered dofetilide in the acute termination of atrial fibrillation and flutter. A multicenter, randomized, double-blind, and placebo-controlled trial. J Am Coll Cardiol 29 [Suppl A]:442AGoogle Scholar
  49. 49.
    Farshi R, Kistner D, Sarma JS, Longmate JA, Singh BN (1999) Ventricular rate control in chronic atrial fibrillation during daily activity and programmed exercise: a crossover open-label study of five drug regimens. Am Coll Cardiol 33:304–310CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2003

Authors and Affiliations

  • G. Chiarandà
    • 1
  • A. Busà
    • 1
  • A. Lazzaro
    • 2
  • T. Regolo
    • 3
  1. 1.U.O di Cardiologia con UTIC Ospedale MuscatelloItaly
  2. 2.Cardiologia, Ospedale GravinaItaly
  3. 3.U.O di Cardiologia, Ospedale FerrarottoCatanzaroItaly

Personalised recommendations